Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 12

TABLE OF CONTENTS Volume 37, Issue 12 (November 2012) In this issue Commentaries Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Bath Salts - The latest Neuropsychopharmacology podcast is now available! In this podcast, Dr. Michael Baumann discusses the mechanism of action of "bath salts", their chemical similarity to MDMA, and the dangers of their use. Listen to the podcast for FREE Dr. Baumann’s accompanying original article is available to read here.   Commentaries Top Long-Term Safety of Stimulant Use for ADHD: Findings from Nonhuman Primates Nora D Volkow Neuropsychopharmacology 2012 37: 2551-2552; 10.1038/npp.2012.127 Full Text A Decade of Pharma Discovery Delivers New Tools Targeting Trace Amine-Associated Receptor 1 Katie R Tallman and David K Grandy Neuropsychopharmacology 2012 37: 2553-2554; 10.1038/npp.2012.148 Full Text Original Articles Top Chronic Treatment with Extended Release Methylphenidate Does Not Alter Dopamine Systems or Increase Vulnerability for Cocaine Self-Administration: A Study in Nonhuman Primates Kathryn E Gill, Peter J Pierre, James Daunais, Allyson J Bennett, Susan Martelle, H Donald Gage, James M Swanson, Michael A Nader and Linda J Porrino Neuropsychopharmacology 2012 37: 2555-2565; advance online publication, July 18, 2012; 10.1038/npp.2012.117 Abstract | Full Text Long-Term Exposure to Oral Methylphenidate or dl-Amphetamine Mixture in Peri-Adolescent Rhesus Monkeys: Effects on Physiology, Behavior, and Dopamine System Development Paul L Soto, Kristin M Wilcox, Yun Zhou, Nancy A Ator, Mark A Riddle, Dean F Wong and Michael R Weed Neuropsychopharmacology 2012 37: 2566-2579; advance online publication, July 18, 2012; 10.1038/npp.2012.119 Abstract | Full Text Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine Florent G Revel, Claas A Meyer, Amyaouch Bradaia, Karine Jeanneau, Eleonora Calcagno, Cédric B André, Markus Haenggi, Marie-Thérèse Miss, Guido Galley, Roger D Norcross, Roberto W Invernizzi, Joseph G Wettstein, Jean-Luc Moreau and Marius C Hoener Neuropsychopharmacology 2012 37: 2580-2592; advance online publication, July 4, 2012; 10.1038/npp.2012.109 Abstract | Full Text Antagonism of Sigma-1 Receptors Blocks Compulsive-Like Eating Pietro Cottone, Xiaofan Wang, Jin Won Park, Marta Valenza, Angelo Blasio, Jina Kwak, Malliga R Iyer, Luca Steardo, Kenner C Rice, Teruo Hayashi and Valentina Sabino Neuropsychopharmacology 2012 37: 2593-2604; advance online publication, June 20, 2012; 10.1038/npp.2012.89 Abstract | Full Text Sex Differences in Selecting Between Food and Cocaine Reinforcement are Mediated by Estrogen Kerry A Kerstetter, Maya A Ballis, Stevie Duffin-Lutgen, Amanda E Carr, Alexandra M Behrens and Tod E Kippin Neuropsychopharmacology 2012 37: 2605-2614; advance online publication, August 8, 2012; 10.1038/npp.2012.99 Abstract | Full Text Effects of Inhibitor of κB Kinase Activity in the Nucleus Accumbens on Emotional Behavior Daniel J Christoffel, Sam A Golden, Mitra Heshmati, Ami Graham, Shari Birnbaum, Rachael L Neve, Georgia E Hodes and Scott J Russo Neuropsychopharmacology 2012 37: 2615-2623; advance online publication, July 11, 2012; 10.1038/npp.2012.121 Abstract | Full Text Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission Alejandro Aparisi Rey, Martin Purrio, Maria-Paz Viveros and Beat Lutz Neuropsychopharmacology 2012 37: 2624-2634; advance online publication, August 1, 2012; 10.1038/npp.2012.123 Abstract | Full Text Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia Nina V Kraguljac, Meredith A Reid, David M White, Jan den Hollander and Adrienne C Lahti Neuropsychopharmacology 2012 37: 2635-2642; advance online publication, July 18, 2012; 10.1038/npp.2012.126 Abstract | Full Text Inhibition of Opioid Transmission at the μ-Opioid Receptor Prevents Both Food Seeking and Binge-Like Eating Chiara Giuliano, Trevor W Robbins, Pradeep J Nathan, Edward T Bullmore and Barry J Everitt Neuropsychopharmacology 2012 37: 2643-2652; advance online publication, July 18, 2012; 10.1038/npp.2012.128 Abstract | Full Text Relative Response Cost Determines the Sensitivity of Instrumental Reward Seeking to Dopamine Receptor Blockade Sean B Ostlund, Alisa R Kosheleff and Nigel T Maidment Neuropsychopharmacology 2012 37: 2653-2660; advance online publication, July 18, 2012; 10.1038/npp.2012.129 Abstract | Full Text Reward Sensitization: Effects of Repeated Nicotine Exposure and Withdrawal in Mice Monica R F Hilario, Jill R Turner and Julie A Blendy Neuropsychopharmacology 2012 37: 2661-2670; advance online publication, July 25, 2012; 10.1038/npp.2012.130 Abstract | Full Text PI3K/Akt Signaling Pathway in the Basolateral Amygdala Mediates the Rapid Antidepressant-like Effects of Trefoil Factor 3 Hai-Shui Shi, Wei-Li Zhu, Jian-Feng Liu, Yi-Xiao Luo, Ji-Jian Si, Shen-Jun Wang, Yan-Xue Xue, Zeng-Bo Ding, Jie Shi and Lin Lu Neuropsychopharmacology 2012 37: 2671-2683; advance online publication, July 25, 2012; 10.1038/npp.2012.131 Abstract | Full Text Investigation of Cortical Glutamate–Glutamine and γ-Aminobutyric Acid in Obsessive–Compulsive Disorder by Proton Magnetic Resonance Spectroscopy Helen B Simpson, Dikoma C Shungu, James Bender, Jr, Xiangling Mao, Xiaoyan Xu, Mark Slifstein and Lawrence S Kegeles Neuropsychopharmacology 2012 37: 2684-2692; advance online publication, August 1, 2012; 10.1038/npp.2012.132 Abstract | Full Text White Matter Disruptions in Adolescents Exposed to Childhood Maltreatment and Vulnerability to Psychopathology Hao Huang, Tejasvi Gundapuneedi and Uma Rao Neuropsychopharmacology 2012 37: 2693-2701; advance online publication, August 1, 2012; 10.1038/npp.2012.133 Abstract | Full Text The Same Antidepressant Elicits Contrasting Patterns of Synaptic Changes in the Amygdala vs Hippocampus Anup Gopalakrishna Pillai, Shobha Anilkumar and Sumantra Chattarji Neuropsychopharmacology 2012 37: 2702-2711; advance online publication, July 25, 2012; 10.1038/npp.2012.135 Abstract | Full Text Central Vasopressin V1A Receptor Blockade Impedes Hypothalamic–Pituitary–Adrenal Habituation to Repeated Restraint Stress Exposure in Adult Male Rats Megan Gray, Leyla Innala and Victor Viau Neuropsychopharmacology 2012 37: 2712-2719; advance online publication, July 25, 2012; 10.1038/npp.2012.136 Abstract | Full Text Impact of a microRNA MIR137 Susceptibility Variant on Brain Function in People at High Genetic Risk of Schizophrenia or Bipolar Disorder Heather C Whalley, Martina Papmeyer, Liana Romaniuk, Emma Sprooten, Eve C Johnstone, Jeremy Hall, Stephen M Lawrie, Kathryn L Evans, Hilary P Blumberg, Jessika E Sussmann and Andrew M McIntosh Neuropsychopharmacology 2012 37: 2720-2729; advance online publication, August 1, 2012; 10.1038/npp.2012.137 Abstract | Full Text White Matter Abnormalities in Pediatric Obsessive-Compulsive Disorder Patricia Gruner, An Vo, Toshikazu Ikuta, Katie Mahon, Bart D Peters, Anil K Malhotra, Aziz M Uluğ and Philip R Szeszko Neuropsychopharmacology 2012 37: 2730-2739; advance online publication, August 8, 2012; 10.1038/npp.2012.138 Abstract | Full Text White Matter Integrity in Highly Traumatized Adults With and Without Post-Traumatic Stress Disorder Negar Fani, Tricia Z King, Tanja Jovanovic, Ebony M Glover, Bekh Bradley, KiSueng Choi, Timothy Ely, David A Gutman and Kerry J Ressler Neuropsychopharmacology 2012 37: 2740-2746; advance online publication, August 8, 2012; 10.1038/npp.2012.146 Abstract | Full Text Advertisement Neuropsychopharmacology Brainpod: Neurotherapeutics The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding. Visit www.nature.com/npp/podcast   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.